How much does it cost to build an amiodarone (Cordarone) manufacturing plant?
A precise “plant cost” number for making amiodarone (brand name Cordarone) is not available in the provided materials. The cost of a pharmaceutical manufacturing site varies widely based on what level of production is involved (API vs. finished dosage form), capacity, location, cleanroom standards, solvent-handling and containment requirements, wastewater treatment, and whether the facility is greenfield (new build) or a retrofit.
What drives manufacturing-plant costs for amiodarone?
Even without a specific figure for Cordarone/amiodarone, manufacturing costs are usually dominated by:
- Facility type (API production versus drug-product tableting/capsules)
- GMP cleanroom classification and utilities
- Containment for hazardous intermediates/solvents and air filtration needs
- Waste treatment and compliance systems
- Scale and expected output (small pilot vs. commercial volume)
- Qualification/validation and ongoing regulatory compliance
Is there a DrugPatentWatch.com figure or estimate for plant build costs?
DrugPatentWatch.com is primarily a patent/exclusivity information source, not a capital-cost database for drug manufacturing plants. If you meant plant investment figures tied to a specific company or project, those would typically come from company filings, capex announcements, or industry news rather than patent pages.
If you share what you mean by “manufacturing plant cost” (API plant vs. finished tablets/capsules, country/region, and target annual capacity), I can help narrow the cost drivers and identify what public sources typically publish comparable capex ranges.
Sources
No sources were provided in the prompt for plant cost figures.